Erosive arthritis and anti-cyclic citrullinated peptide antibodies in systemic sclerosis

Background: The frequency and characteristics of erosive arthritis in systemic sclerosis (SSc) remains unclear. The aim of the study was to determine the prevalence and characteristics of erosive arthritis and to define the role of anti-CCP antibodies in the differential diagnosis of joint involveme...

Full description

Saved in:
Bibliographic Details
Main Authors: A Abdessemed, N Khaldoun, A Tahiat, R Djidjik, Y Mellal, I Allam, S Slimani, A Haddouche, N Brahimi, M Ghaffor, A Ladjouze Rezig
Format: Article
Language:English
Published: SAGE Publishing 2017-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=2;spage=81;epage=85;aulast=Abdessemed
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849413163310645248
author A Abdessemed
N Khaldoun
A Tahiat
R Djidjik
Y Mellal
I Allam
S Slimani
A Haddouche
N Brahimi
M Ghaffor
A Ladjouze Rezig
author_facet A Abdessemed
N Khaldoun
A Tahiat
R Djidjik
Y Mellal
I Allam
S Slimani
A Haddouche
N Brahimi
M Ghaffor
A Ladjouze Rezig
author_sort A Abdessemed
collection DOAJ
description Background: The frequency and characteristics of erosive arthritis in systemic sclerosis (SSc) remains unclear. The aim of the study was to determine the prevalence and characteristics of erosive arthritis and to define the role of anti-CCP antibodies in the differential diagnosis of joint involvement in SSc. Methods: One hundred and fifty patients who met the 1980 American College of Rheumatology (ACR) criteria and/or Leroy and Medsger criteria for SSc were assessed. Results: Among the 150 SSc patients, 139 were women. Their median age was 45.12 ± 13.59 years and disease duration ( first non-Raynaud symptom) of 9.7 years. Of these patients, 5 patients were classified as having limited SSc, 103 as limited cutaneous SSc and 42 as diffuse cutaneous SSc. Joint involvement was characterized as arthralgia in 95 (63%) patients, arthritis in 60 (40%) patients, erosive arthritis in 21 (14%) and systemic sclerosis (SSc)-rheumatoid arthritis (RA) overlap syndrome in 7 patients. The prevalence of diffuse cutaneous involvement (50%) (P = 0.01), digital ulcers (81%) (P = 0.009), interstitial lung disease (81%) (P = 0.009) and anti-topoisomerase I antibodies (P = 0.01) was higher in patients with erosive arthritis. Anti-CCP antibodies were found in 14 of the 150 (9.4%) cases. A statistically significant association between the presence of anti-CCP antibodies and the presence of arthritis (P = 0.01), erosive arthritis (P = 0.01) and SSc-RA overlap syndrome (P < 0.05) was noted. High titers of anti-CCP antibodies were found in patients with SSc-RA overlap syndrome. Conclusion: Erosive arthritis is not rare in SSc, and it might be a marker of severe disease. Anti-CCP antibodies can be present in patients with SSc, and high titers of anti-CCP antibodies may be indicative of SSc-RA overlap syndrome.
format Article
id doaj-art-5c80666df5584c27b1cc29d34ca82eab
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2017-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-5c80666df5584c27b1cc29d34ca82eab2025-08-20T03:34:13ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012017-01-01122818510.4103/injr.injr_46_16Erosive arthritis and anti-cyclic citrullinated peptide antibodies in systemic sclerosisA AbdessemedN KhaldounA TahiatR DjidjikY MellalI AllamS SlimaniA HaddoucheN BrahimiM GhafforA Ladjouze RezigBackground: The frequency and characteristics of erosive arthritis in systemic sclerosis (SSc) remains unclear. The aim of the study was to determine the prevalence and characteristics of erosive arthritis and to define the role of anti-CCP antibodies in the differential diagnosis of joint involvement in SSc. Methods: One hundred and fifty patients who met the 1980 American College of Rheumatology (ACR) criteria and/or Leroy and Medsger criteria for SSc were assessed. Results: Among the 150 SSc patients, 139 were women. Their median age was 45.12 ± 13.59 years and disease duration ( first non-Raynaud symptom) of 9.7 years. Of these patients, 5 patients were classified as having limited SSc, 103 as limited cutaneous SSc and 42 as diffuse cutaneous SSc. Joint involvement was characterized as arthralgia in 95 (63%) patients, arthritis in 60 (40%) patients, erosive arthritis in 21 (14%) and systemic sclerosis (SSc)-rheumatoid arthritis (RA) overlap syndrome in 7 patients. The prevalence of diffuse cutaneous involvement (50%) (P = 0.01), digital ulcers (81%) (P = 0.009), interstitial lung disease (81%) (P = 0.009) and anti-topoisomerase I antibodies (P = 0.01) was higher in patients with erosive arthritis. Anti-CCP antibodies were found in 14 of the 150 (9.4%) cases. A statistically significant association between the presence of anti-CCP antibodies and the presence of arthritis (P = 0.01), erosive arthritis (P = 0.01) and SSc-RA overlap syndrome (P < 0.05) was noted. High titers of anti-CCP antibodies were found in patients with SSc-RA overlap syndrome. Conclusion: Erosive arthritis is not rare in SSc, and it might be a marker of severe disease. Anti-CCP antibodies can be present in patients with SSc, and high titers of anti-CCP antibodies may be indicative of SSc-RA overlap syndrome.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=2;spage=81;epage=85;aulast=AbdessemedAnti-CCPerosive arthritissystemic sclerosis
spellingShingle A Abdessemed
N Khaldoun
A Tahiat
R Djidjik
Y Mellal
I Allam
S Slimani
A Haddouche
N Brahimi
M Ghaffor
A Ladjouze Rezig
Erosive arthritis and anti-cyclic citrullinated peptide antibodies in systemic sclerosis
Indian Journal of Rheumatology
Anti-CCP
erosive arthritis
systemic sclerosis
title Erosive arthritis and anti-cyclic citrullinated peptide antibodies in systemic sclerosis
title_full Erosive arthritis and anti-cyclic citrullinated peptide antibodies in systemic sclerosis
title_fullStr Erosive arthritis and anti-cyclic citrullinated peptide antibodies in systemic sclerosis
title_full_unstemmed Erosive arthritis and anti-cyclic citrullinated peptide antibodies in systemic sclerosis
title_short Erosive arthritis and anti-cyclic citrullinated peptide antibodies in systemic sclerosis
title_sort erosive arthritis and anti cyclic citrullinated peptide antibodies in systemic sclerosis
topic Anti-CCP
erosive arthritis
systemic sclerosis
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=2;spage=81;epage=85;aulast=Abdessemed
work_keys_str_mv AT aabdessemed erosivearthritisandanticycliccitrullinatedpeptideantibodiesinsystemicsclerosis
AT nkhaldoun erosivearthritisandanticycliccitrullinatedpeptideantibodiesinsystemicsclerosis
AT atahiat erosivearthritisandanticycliccitrullinatedpeptideantibodiesinsystemicsclerosis
AT rdjidjik erosivearthritisandanticycliccitrullinatedpeptideantibodiesinsystemicsclerosis
AT ymellal erosivearthritisandanticycliccitrullinatedpeptideantibodiesinsystemicsclerosis
AT iallam erosivearthritisandanticycliccitrullinatedpeptideantibodiesinsystemicsclerosis
AT sslimani erosivearthritisandanticycliccitrullinatedpeptideantibodiesinsystemicsclerosis
AT ahaddouche erosivearthritisandanticycliccitrullinatedpeptideantibodiesinsystemicsclerosis
AT nbrahimi erosivearthritisandanticycliccitrullinatedpeptideantibodiesinsystemicsclerosis
AT mghaffor erosivearthritisandanticycliccitrullinatedpeptideantibodiesinsystemicsclerosis
AT aladjouzerezig erosivearthritisandanticycliccitrullinatedpeptideantibodiesinsystemicsclerosis